AI Terminal
PORVAIR PLC
Quarterly Report • Jul 4, 2022
5280_ir_2022-07-04_443f674b-6757-47d8-9107-0e22aa0f38c3.html
Quarterly Report
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information 
RNS Number : 1041R
Porvair PLC
04 July 2022
For immediate release 4 July 2022
Porvair plc
Interim results for the six months ended 31 May 2022
Porvair plc ("Porvair" or "the Group"), the specialist filtration, laboratory and environmental technology group, announces its interim results for the six months ended 31 May 2022 ("H1 2022" or the "period").
Highlights:
· Revenue 18% higher at £82.3 million (2021: £69.7 million), 16% higher on a constant currency basis*.
· Operating profit 9% higher at £10.1 million (2021: £9.3 million).
· Adjusted operating profit* 14% higher at £10.4 million (2021: £9.1 million).
· Profit before tax 7% higher at £9.5 million (2021: £8.9 million).
· Adjusted profit before tax* 14% higher at £9.8 million (2021: £8.6 million).
· Adjusted basic earnings per share* were 16.6 pence (2021: 14.8 pence).
· Basic earnings per share were 16.1 pence (2021: 16.4 pence, flattered by adjusting items. See note 1).
· Net cash was £12.2 million (31 May 2021: £6.2 million; 30 November 2021: £10.2 million) after investing £2.3 million (2021: £2.0 million) in capital expenditure.
· Interim dividend increased 0.1 pence per share to 1.9 pence (2021: 1.8 pence).
Commenting on the outlook, Ben Stocks, Chief Executive, said:
"This is a record set of Interim results with growth in all three divisions, showing that the Group is performing well and has managed wide-spread supply dislocation and inflationary pressures satisfactorily thus far. Porvair remains well positioned to address long-term global growth trends: tightening environmental regulations; growth in analytical science; the need for clean water; carbon-efficient transportation; the replacement of plastic and steel with aluminium; and the drive for manufacturing process quality and efficiency.
The strong current order book is flattered in places by extended lead times, but the underlying order position remains healthy, with aerospace and laboratory demand notably stronger than one year ago. The focus for the coming months is on margins. The Group will continue to pass on cost increases where necessary and has accelerated investments in productivity. 2022 has started strongly and provided economic conditions allow the outlook for the balance of the year is promising."
*See notes 1, 2 and 3 for definitions and reconciliations.
For further information please contact:
| Porvair plc | 01553 765 500 | ||
| Ben Stocks, Chief Executive | |||
| James Mills, Group Finance Director | |||
| Buchanan Communications | 020 7466 5000 | ||
| Charles Ryland / Steph Whitmore / George Cleary |
An analyst briefing will take place at 9:30 a.m. on Monday 4 July 2022, please contact Buchanan if you wish to join. An audiocast of the meeting and the presentation will subsequently be made available at www.porvair.com
Operating review
The last twelve months have seen revenue and earnings growth despite headwinds from supply-side challenges and inflationary pressures. At the start of 2022, supply chain dislocation had started to ease somewhat, but inflationary pressure continued to build and war in Europe, along with renewed covid outbreaks in China, increased volatility. While the Group has navigated these issues satisfactorily thus far, we remain vigilant and expect inflationary and supply problems to persist well into 2023.
Despite these conditions the Group delivered revenue growth of 18% in the first half of 2022, with all three divisions contributing. Excluding currency and acquisitions, revenue growth was 15%. This was in part driven by strong order books through the period, and in part due to price increases implemented over the last year. Laboratory demand was expected to settle as the direct effects of the pandemic eased, but this has not noticeably been the case yet. The aerospace forward orderbook is better than it has been since 2019. Aluminium production is also robust.
In inflationary times the management of margin is critical. We pass on direct cost increases and have stepped up investments aimed at productivity and automation. Porvair's devolved management structure is helpful in these conditions with key cost, price and inventory decisions made close to the market.
Financial summary
| H1 2022 | H1 2021 | Growth | |||
| £m | £m | % | |||
| Revenue | 82.3 | 69.7 | 18 | ||
| Operating profit | 10.1 | 9.3 | 9 | ||
| Adjusted operating profit* | 10.4 | 9.1 | 14 | ||
| Profit before tax | 9.5 | 8.9 | 7 | ||
| Adjusted profit before tax* | 9.8 | 8.6 | 14 | ||
| Pence | Pence | ||||
| Earnings per share | 16.1 | 16.4 | (2) | ||
| Adjusted earnings per share* | 16.6 | 14.8 | 12 | ||
| £m | £m | ||||
| Cash generated from operations | 7.2 | 6.1 | |||
| Net cash (excluding lease liabilities) | 12.2 | 6.2 |
*See notes 1, 2 and 3 for definitions and reconciliations.
Revenue was 18% higher (16% at constant currency). Operating profit was 9% higher at £10.1 million. Profit before tax increased by 7%. Adjusted earnings per share increased 12% to 16.6 pence. Net cash at 31 May 2022 was £12.2 million.
The Group's record for growth, cash generation and investment is as follows:
| 5 years | 10 years | 15 years | ||
| CAGR* | CAGR* | CAGR* | ||
| Revenue growth | 7% | 8% | 9% | |
| Earnings per share growth | 8% | 12% | 10% | |
| Adjusted earnings per share growth | 9% | 12% | 10% | |
| £m | £m | £m | ||
| Cash from operations | 81.9 | 141.8 | 175.7 | |
| Investment in acquisitions and capital expenditure | 43.1 | 76.6 | 93.9 |
* Compound annual growth rate
Porvair's strategy and purpose has remained consistent for over 17 years, a period that now encompasses two recessions, a pandemic, and many years of growth. This longer-term growth record gives the Board confidence in the Group's capabilities and is the basis for longer-term capital allocation and planning decisions.
Strategic statement and business model
Porvair's strategic purpose is the development of specialist filtration, laboratory and environmental technology businesses for the benefit of all stakeholders. Principal measures of success include consistent earnings growth and selected ESG measures. The Group publishes a full ESG report at the time of the annual Final Results.
The Group is positioned to benefit from global trends: tightening environmental regulations; growth in analytical science; the need for clean water; carbon-efficient transportation; the replacement of plastic and steel by aluminium; and the drive for manufacturing process quality and efficiency.
Porvair businesses have certain key characteristics in common:
· Specialist design or engineering skills are required;
· Product use and replacement is mandated by regulation, quality accreditation or a maintenance cycle; and
· Products are typically designed into a system that will have a long life-cycle and must perform to a given specification.
Orders are won by offering the best technical solutions at an acceptable commercial cost. Technical expertise is necessary in all markets served. New products are often adaptations of existing designs with attributes validated in our own test and measurement laboratories. Experience in specific markets and applications is valuable in building customer confidence. Domain knowledge is important, as is deciding where to direct resources.
This leads the Group to:
1. Focus on markets with long-term growth potential.
2. Look for applications where product use is mandated and replacement demand is regular.
3. Make new product development a core business activity.
4. Establish geographic presence where end-markets require.
5. Invest in both organic and acquired growth.
Therefore:
· We focus on three operating segments: Aerospace & Industrial; Laboratory; and Metal Melt Quality. All have clear long-term growth drivers.
· Our products typically reduce emissions or protect complex downstream systems and, as a result, are replaced regularly. A high proportion of our annual revenue is from repeat orders.
· Through a focus on new product development, we aim to generate growth rates in excess of the underlying market. Where possible, we build intellectual property around our product developments.
· Our geographic presence follows the markets we serve. In the last twelve months, 49% of revenue was in the Americas; 18% in Asia; 22% in Continental Europe; and 10% in the UK; and 1% in Africa. The Group has plants in the US, UK, Germany, the Netherlands and China. In the last twelve months, 51% of revenue was manufactured in the US; 30% in the UK; 15% in Continental Europe; and 4% in China.
· We aim to meet dividend and investment needs from free cash flow and modest borrowing facilities. In recent years we have expanded manufacturing capacity in the UK, Germany, US and China, and have made several acquisitions. All investments are subject to a hurdle rate analysis based on strategic and financial priorities.
Environmental, Social and Governance ('ESG')
The Board understands that responsible business development is essential for creating long-term value for stakeholders. Most of the products made by Porvair are used to the benefit of the environment. Our water analysis equipment measures contamination levels in water. Industrial filters are typically needed to reduce emissions or improve efficiency. Aerospace filters improve safety and reliability. Nuclear filters confine fissile materials. Metal Melt Quality filters reduce waste and help improve the strength to weight ratio of metal components.
A full ESG report was published in February 2022 setting out the Group's ESG management framework and goals. This will be updated in February 2023.
Divisional review
Aerospace & Industrial
| H1 2022 | H1 2021 | Growth | |||
| £m | £m | % | |||
| Revenue | 30.7 | 26.0 | 18 | ||
| Operating profit | 2.9 | 2.1 | 38 | ||
| Adjusted operating profit* | 3.1 | 2.5 | 24 |
*See notes 1, 2 and 3 for definitions and reconciliations.
The Aerospace & Industrial division designs and manufactures a wide range of specialist filtration products, demand for which is driven by customers seeking better engineered, cleaner, safer or more efficient operations. Differentiation is achieved through design engineering; the development of intellectual property; and quality accreditations.
Revenue in the period increased by 18%. Aerospace revenues increased for the first time since 2019 and the forward order book is returning to more normal levels. We have used the pandemic-induced quieter period since 2020 to invest in automation and productivity and the benefits of this are starting to materialise as aerospace volume returns. Industrial filtration has started 2022 well. Timing of certain petrochemical contracts has drifted but this has been balanced by strong demand in general industrial filtration in both the US and Europe. Microelectronics continues to grow. With better aerospace volumes, adjusted margins are higher in 2022 at 10.1%.
Laboratory
| H1 2022 | H1 2021 | Growth | ||||
| £m | £m | % | ||||
| Revenue | 30.8 | 25.2 | 22 | |||
| Operating profit | 5.9 | 4.9 | 20 | |||
| Adjusted operating profit* | 6.1 | 4.8 | 27 |
*See notes 1, 2 and 3 for definitions and reconciliations.
The Laboratory division has two operating businesses: Porvair Sciences (including JGF Finneran and Kbio) and Seal Analytical.
· Porvair Sciences manufactures laboratory filters, small instruments and associated consumables. Differentiation is achieved through proprietary manufacturing capabilities and filtration media.
· Seal Analytical is a leading supplier of instruments and consumables for environmental laboratories, for which demand is driven by water quality regulations. Differentiation is achieved through consistent new product development.
Revenue grew by 22% in the period, or 19% excluding acquisitions. Demand for laboratory consumables remained robust, while demand for covid-related components fell, but by less than expected. Seal Analytical sales were up 18%.
The division continues to perform strongly, driven by the global expansion in diagnostic, analytic and environmental laboratory capacity. The Group's expertise is in sample preparation products, chromatography consumables and clean water analysis. Investment has been made in expanding capacity, improving sales channels and accelerating new product development. Seal Analytical has a good record of product introductions. Its latest analyser, which incorporates robotic handling capability, has secured its first sales in 2022. Adjusted operating margins in the division were steady at 19.8%.
Metal Melt Quality
| H1 2022 | H1 2021 | Growth | |||
| £m | £m | % | |||
| Revenue | 20.8 | 18.4 | 13 | ||
| Operating profit | 2.8 | 3.6 | (22) | ||
| Adjusted operating profit* | 2.8 | 3.0 | (7) |
*See notes 1, 2 and 3 for definitions and reconciliations.
The Metal Melt Quality division manufactures filters for molten aluminium, ductile iron and nickel-cobalt alloys. It has a well-differentiated product range based on patented products and a promising new product pipeline.
Revenue grew by 13%, helped by a partial recovery of aerospace-related filters. Aluminium demand in 2022 has been robust, driven by the switch from plastic to recyclable aluminium in beverage packaging and the higher proportion of aluminium used in electric and hybrid vehicles.
As outlined this time last year, adjusted margins in H1 2021 (16.3%) were flattered by lower sales and marketing costs. The Board notes that the 13.5% adjusted operating margin recorded in H1 2022 is good relative to historic averages and is driven by operational efficiency, productivity investments, and active management of cost and price issues.
Alternative performance measures
| H1 2022 | H1 2021 | Growth | |||
| £m | £m | % | |||
| Adjusted operating profit | 10.4 | 9.1 | 14 | ||
| Adjusted profit before tax | 9.8 | 8.6 | 14 | ||
| Adjusted profit after tax | 7.6 | 6.8 | 12 |
The Group presents alternative performance measures to enable a better understanding of its trading performance. Adjusted operating profit and adjusted profit before tax exclude items that are considered significant and where treatment as an adjusting item provides a more consistent assessment of the Group's trading. Adjusted operating profit excludes a £0.3 million charge for the amortisation of acquired intangible assets (2021: £0.3 million of net income) from operating profit. The details of these adjustments are set out in note 1.
Finance costs
The Group incurred an interest charge of £0.6 million (2021: £0.5 million): £0.1 million (2021: £0.2 million) relates to the finance cost of the defined benefit pension scheme; £0.2 million (2021: £0.2 million) relates to the interest charge on lease liabilities; and £0.1 million (2021: £0.1 million) relates to the cost of unwinding discounts on provisions and other payables. The remainder comprises undrawn commitment fees and interest on the Group's banking facilities.
Tax
The Group tax charge was £2.1 million (2021: £1.3 million), including the tax effect of adjusting items (see note 1). The adjusted income tax expense was £2.2 million (2021: £1.8 million), with the underlying rate of income tax for the period on adjusted measures being 22% (2021: 21%).
Earnings per share and dividends
The basic earnings per share for the period was 16.1 pence (2021: 16.4 pence). Adjusted earnings per share was 16.6 pence (2021: 14.8 pence).
The Board has declared an interim dividend of 1.9 pence (2021: 1.8 pence) per share.
Investment
In the last five years, £43.1 million has been invested in acquisitions and capacity expansion. The Group invested £2.3 million in capital expenditure in the first half of 2022 (2021: £2.0 million).
Cash flow, cash and net debt
Cash generated from operations in the six months to 31 May 2022 was £7.2 million (2021: £6.1 million). The Group normally sees an outflow of working capital in the first half of the year. Working capital increased by £4.9 million (2021: £3.8 million) in the period.
Net cash at 31 May 2022 was £12.2 million (31 May 2021: £6.2 million; 30 November 2021: £10.2 million). Lease liabilities were £11.5 million (31 May 2021: £12.8 million; 30 November 2021: £12.2 million).
Provisions and contingent liabilities
The Group has £4.5 million (30 November 2021: £4.7 million) of provisions for dilapidations and warranty risks.
The Group has outstanding performance bonds with customers at 31 May 2022 of $2.5 million (30 November 2021: $2.5 million) and €0.4 million (30 November 2021: €0.8 million).
Return on capital employed
The Group's return on capital employed was 13% (2021: 11%). Excluding the impact of goodwill and the pension deficit, the return on operating capital employed was 33% (2021: 29%).
Outlook
While the Group has managed supply dislocation and inflationary pressure satisfactorily thus far, both are expected to persist for the rest of 2022. Longer-term, Porvair remains well positioned to address global growth trends: tightening environmental regulations; growth in analytical science; the need for clean water; carbon-efficient transportation; the replacement of plastic and steel by aluminium; and the drive for manufacturing process quality and efficiency.
The strong current order book is flattered in places by extended lead times, but the underlying order position remains healthy, with aerospace and laboratory demand notably stronger than one year ago. The focus for the coming months is on margins. The Group will continue to pass on cost increases where necessary and has accelerated investments in productivity. 2022 has started strongly and provided economic conditions allow the outlook for the balance of the year is promising.
Ben Stocks
Group Chief Executive
1 July 2022
Related parties
Other than remuneration of key management personnel, there were no related party transactions in the six months ended 31 May 2022 (2021: none).
Principal risks
Each division considers strategic, operational and financial risks and identifies actions to mitigate those risks. These risk profiles are reviewed by the Board and updated at least annually. Further details of the Group's risk profile analysis can be found in the Strategic Report section of the Annual Report & Accounts for the year ended 30 November 2021.
Certain elements of the Group's order position can change quickly in the face of changing economic circumstances. The Metal Melt Quality division, Laboratory division and general industrial filtration within the Aerospace & Industrial division all have relatively short lead times and order cycles and, therefore, revenue is subject to fluctuations which could have a material effect on the Group's results for the balance of 2022.
Forward-looking statements
Certain statements in this interim financial information are forward-looking. Although the Group believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that these expectations will prove to have been correct. Because these statements involve risks and uncertainties, actual results may differ materially from those expressed or implied by these forward-looking statements.
We undertake no obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
Condensed consolidated income statement
For the six months ended 31 May
| Six months ended 31 May | |||||
| 2022 | 2021 | ||||
| Note | Unaudited | Unaudited | |||
| £'000 | £'000 | ||||
| Revenue | 1,2 | 82,280 | 69,654 | ||
| Cost of sales | (55,018) | (46,759) | |||
| Gross profit | 27,262 | 22,895 | |||
| Other operating expenses | (17,185) | (13,566) | |||
| Adjusted operating profit | 1,2 | 10,412 | 9,066 | ||
| Adjustments: | |||||
| Amortisation of acquired intangible assets | (335) | (402) | |||
| Other acquisition-related adjustments | - | (80) | |||
| Impairment of assets and restructuring costs | - | (592) | |||
| Paycheck Protection Program | - | 1,337 | |||
| Operating profit | 1,2 | 10,077 | 9,329 | ||
| Finance costs | (566) | (479) | |||
| Profit before tax | 9,511 | 8,850 | |||
| Adjusted income tax expense | (2,202) | (1,768) | |||
| Adjustments: | |||||
| Tax effect of adjustments to operating profit | 1 | 67 | 472 | ||
| Income tax expense | (2,135) | (1,296) | |||
| Profit for the period | 7,376 | 7,554 | |||
| Earnings per share (basic) | 3 | 16.1p | 16.4p | ||
| Earnings per share (diluted) | 3 | 16.1p | 16.4p | ||
| Adjusted earnings per share (basic) | 3 | 16.6p | 14.8p | ||
| Adjusted earnings per share (diluted) | 3 | 16.6p | 14.8p |
Condensed consolidated statement of comprehensive income
For the six months ended 31 May
| Six months ended 31 May | |||||
| 2022 Unaudited £'000 |
2021 Unaudited £'000 |
||||
| Note | |||||
| Profit for the period | 7,376 | 7,554 | |||
| Other comprehensive income/(expense) | |||||
| Items that will not be reclassified to profit and loss: | |||||
| Actuarial gain in defined benefit pension plans net of tax | 9 | 3,037 | 2,515 | ||
| Items that may be subsequently reclassified to profit or loss: | |||||
| Exchange gain/(loss) on translation of foreign subsidiaries | 3,329 | (4,301) | |||
| Total other comprehensive income/(expense) for the period | 6,366 | (1,786) | |||
| Total comprehensive income for the period | 13,742 | 5,768 | |||
The accompanying notes are an integral part of this interim financial information.
Condensed consolidated balance sheet
As at 31 May
| As at 31 May | As at 30 November | |||||
| Note | 2022 Unaudited |
2021 Unaudited |
2021 Audited |
|||
| £'000 | £'000 | £'000 | ||||
| Non-current assets | ||||||
| Property, plant and equipment | 22,705 | 20,427 | 21,235 | |||
| Right-of-use assets | 10,207 | 11,878 | 11,014 | |||
| Goodwill and other intangible assets | 75,630 | 71,962 | 74,103 | |||
| Deferred tax asset | 342 | 1,257 | 1,821 | |||
| 108,884 | 105,524 | 108,173 | ||||
| Current assets | ||||||
| Inventories | 28,266 | 24,418 | 24,650 | |||
| Trade and other receivables | 28,109 | 22,428 | 21,344 | |||
| Derivative financial instruments | - | 214 | - | |||
| Cash and cash equivalents | 15,988 | 15,501 | 15,442 | |||
| 72,363 | 62,561 | 61,436 | ||||
| Current liabilities | ||||||
| Trade and other payables | (28,478) | (23,429) | (21,702) | |||
| Current tax liabilities | (1,246) | (469) | (853) | |||
| Borrowings | - | (1,796) | - | |||
| Lease liabilities | (2,097) | (2,071) | (2,207) | |||
| Derivative financial instruments | (269) | - | (20) | |||
| Provisions | 8 | (4,177) | (3,884) | (4,372) | ||
| (36,267) | (31,649) | (29,154) | ||||
| Net current assets | 36,096 | 30,912 | 32,282 | |||
| Non-current liabilities | ||||||
| Borrowings | (3,754) | (7,553) | (5,217) | |||
| Deferred tax liability | (2,472) | (2,835) | (2,425) | |||
| Retirement benefit obligations | 9 | (7,102) | (10,871) | (12,602) | ||
| Other payables | (900) | (1,900) | (945) | |||
| Lease liabilities | (9,395) | (10,682) | (10,024) | |||
| Provisions | 8 | (312) | (282) | (296) | ||
| (23,935) | (34,123) | (31,509) | ||||
| Net assets | 121,045 | 102,313 | 108,946 | |||
| Capital and reserves | ||||||
| Share capital | 924 | 923 | 924 | |||
| Share premium account | 37,078 | 36,981 | 37,078 | |||
| Cumulative translation reserve | 10,986 | 3,344 | 7,657 | |||
| Retained earnings | 72,057 | 61,065 | 63,287 | |||
| Equity attributable to owners of the parent | 121,045 | 102,313 | 108,946 |
The interim financial information was approved by the Board of Directors on 1 July 2022 and was signed on its behalf by:
Ben Stocks James Mills
Group Chief Executive Group Finance Director
The accompanying notes are an integral part of this interim financial information.
Condensed consolidated cash flow statement
For the six months ended 31 May
| Six months ended 31 May | ||||
| Note | 2022 Unaudited | 2021 Unaudited | ||
| £'000 | £'000 | |||
| Cash flows from operating activities | ||||
| Cash generated from operations | 5 | 7,239 | 6,078 | |
| Interest paid | (194) | (138) | ||
| Tax paid | (1,400) | (916) | ||
| Net cash generated from operating activities | 5,645 | 5,024 | ||
| Cash flows from investing activities | ||||
| Acquisition of subsidiaries (net of cash acquired) | - | (1,694) | ||
| Purchase of property, plant and equipment | (2,310) | (1,987) | ||
| Purchase of intangible assets | (43) | (14) | ||
| Proceeds from sale of property, plant and equipment | 16 | - | ||
| Net cash used in investing activities | (2,337) | (3,695) | ||
| Cash flows from financing activities | ||||
| Net proceeds from the issue of ordinary shares | - | 54 | ||
| Purchase of Employee Benefit Trust shares | (406) | (332) | ||
| (Decrease)/increase in borrowings | 6 | (1,350) | 434 | |
| Repayment of lease liabilities | (1,208) | (1,137) | ||
| Net cash used in financing activities | (2,964) | (981) | ||
| Net increase in cash and cash equivalents | 6 | 344 | 348 | |
| Exchange gains/(losses) on cash and cash equivalents | 202 | (410) | ||
| 546 | (62) | |||
| Cash and cash equivalents at the beginning of the period | 15,442 | 15,563 | ||
| Cash and cash equivalents at the end of the period | 15,988 | 15,501 |
The accompanying notes are an integral part of this interim financial information.
Condensed consolidated statement of changes in equity
For the six months ended 31 May (Unaudited)
| Share capital £'000 |
Share premium account £'000 |
Cumulative translation reserve £'000 |
Retained earnings £'000 |
Total £'000 |
|
| Balance at 1 December 2020 | 923 | 36,927 | 7,645 | 52,697 | 98,192 |
| Profit for the period | - | - | - | 7,554 | 7,554 |
| Other comprehensive income/(expense) | - | - | (4,301) | 2,515 | (1,786) |
| Total comprehensive income for the period | - | - | (4,301) | 10,069 | 5,768 |
| Purchase of own shares (held in trust) | - | - | - | (332) | (332) |
| Issue of ordinary share capital | - | 54 | - | - | 54 |
| Employee share option schemes | - | - | - | 148 | 148 |
| Ordinary share dividends | - | - | - | (1,517) | (1,517) |
| Balance at 31 May 2021 | 923 | 36,981 | 3,344 | 61,065 | 102,313 |
| Share capital £'000 |
Share premium account £'000 |
Cumulative translation reserve £'000 |
Retained earnings £'000 |
Total £'000 |
|
| Balance at 1 December 2021 | 924 | 37,078 | 7,657 | 63,287 | 108,946 |
| Profit for the period | - | - | - | 7,376 | 7,376 |
| Other comprehensive income | - | - | 3,329 | 3,037 | 6,366 |
| Total comprehensive income for the period | - | - | 3,329 | 10,413 | 13,742 |
| Purchase of own shares (held in trust) | - | - | - | (406) | (406) |
| Employee share option schemes | - | - | - | 369 | 369 |
| Ordinary share dividends | - | - | - | (1,606) | (1,606) |
| Balance at 31 May 2022 | 924 | 37,078 | 10,986 | 72,057 | 121,045 |
The accompanying notes are an integral part of this interim financial information.
Notes to the condensed interim consolidated financial information
1. Alternative performance measures
Alternative performance measures are used by the Directors and management to monitor business performance internally and exclude certain cash and non-cash items which they believe are not reflective of the normal course of business of the Group. The Directors believe that disclosing such non-IFRS measures enables a reader to isolate and evaluate the impact of such items on results and allows for a fuller understanding of performance from year to year. Alternative performance measures may not be directly comparable with other similarly titled measures used by other companies.
Alternative revenue measures
| Six months ended 31 May | ||||||
| 2022 | 2021 | Growth | ||||
| Aerospace & Industrial | £'000 | £'000 | % | |||
| Revenue at constant currency | 29,971 | 25,564 | 17 | |||
| Exchange | 714 | 481 | ||||
| Revenue as reported | 30,685 | 26,045 | 18 | |||
| Laboratory | ||||||
| Underlying revenue | 26,371 | 22,504 | 17 | |||
| Acquisitions | 3,469 | 2,296 | ||||
| Revenue at constant currency | 29,840 | 24,800 | 20 | |||
| Exchange | 935 | 445 | ||||
| Revenue as reported | 30,775 | 25,245 | 22 | |||
| Metal Melt Quality | ||||||
| Revenue at constant currency | 19,355 | 17,841 | 8 | |||
| Exchange | 1,465 | 523 | ||||
| Revenue as reported | 20,820 | 18,364 | 13 | |||
| Group | ||||||
| Underlying revenue | 75,697 | 65,909 | 15 | |||
| Acquisitions | 3,469 | 2,296 | ||||
| Revenue at constant currency | 79,166 | 68,205 | 16 | |||
| Exchange | 3,114 | 1,449 | ||||
| Revenue as reported | 82,280 | 69,654 | 18 |
Revenue at constant currency is derived from translating overseas subsidiaries results at budgeted fixed exchange rates. In 2022 and 2021, the rates used were $1.40:£1 and €1.20:£1, compared with reported rates of $1.31:£1 (2021: $1.38:£1) and €1.19:£1 (2021: €1.14:£1).
Underlying revenue is revenue at constant currency adjusted for the impact of acquisitions made in the current and prior year.
Alternative profit measures
A reconciliation of the Group's adjusted performance measures to the reported IFRS measures is presented below:
| H1 2022 | H1 2021 | |||||||
| Adjusted | Adjustments | Reported | Adjusted | Adjustments | Reported | |||
| £'000 | £'000 | £'000 | £'000 | £'000 | £'000 | |||
| Operating profit | 10,412 | (335) | 10,077 | 9,066 | 263 | 9,329 | ||
| Finance costs | (566) | - | (566) | (479) | - | (479) | ||
| Profit before tax | 9,846 | (335) | 9,511 | 8,587 | 263 | 8,850 | ||
| Income tax expense | (2,202) | 67 | (2,135) | (1,768) | 472 | (1,296) | ||
| Profit for the period | 7,644 | (268) | 7,376 | 6,819 | 735 | 7,554 | ||
An analysis of adjusting items is given below:
| 2022 | 2021 | ||
| Affecting operating profit | £'000 | £'000 | |
| Amortisation of acquired intangible assets | (335) | (402) | |
| Other acquisition-related adjustments | - | (80) | |
| Impairment of assets and restructuring costs | - | (592) | |
| Paycheck Protection Program | - | 1,337 | |
| (335) | 263 | ||
| Affecting tax | |||
| Tax effect of adjustments to operating profit | 67 | 472 | |
| Total adjusting items | (268) | 735 |
Adjusted operating profit excludes:
· The amortisation of intangible assets arising on acquisition of businesses of £0.3 million (2021: £0.4 million);
· Other acquisition-related costs of £nil (2021: £0.1 million in relation to the acquisition of Kbio);
· Covid-19 related impairment of assets and restructuring costs of £nil (2021: £0.6 million, principally within the Aerospace & Industrial division); and
· Monies received under the US Paycheck Protection Program of £nil (2021: £1.3 million, for proceeds received in relation to eligible costs incurred within the US operations during the covid pandemic, as disclosed in the Annual Report & Accounts for the year ended 30 November 2021).
The 2021 tax effect of adjustments to operating profit includes a credit in relation to eligible costs incurred in the prior year, associated with the US Paycheck Protection Program and previously treated as disallowed for tax. The £1.3 million Paycheck Protection Program income in 2021 does not attract US tax. These items combined contribute to the tax credit on net adjusting items.
2. Segmental information
The chief operating decision maker has been identified as the Board of Directors. The Board of Directors has instructed the Group's internal reporting to be based around differences in products and services, in order to assess performance and allocate resources. Management has determined the operating segments based on this reporting.
As at 31 May 2022, the Group is organised on a worldwide basis into three operating segments:
1) Aerospace & Industrial - principally serving the aviation, and energy and industrial markets;
2) Laboratory - principally serving the bioscience and environmental laboratory instrument and consumables market; and
3) Metal Melt Quality - principally serving the global aluminium, North American Free Trade Agreement (NAFTA) iron foundry and super-alloys markets.
Other Group operations' costs, assets and liabilities are included in the "Central" division. Central costs mainly comprise Group corporate costs, including new business development costs, some research and development costs and general financial costs. Central assets and liabilities mainly comprise Group retirement benefit obligations, tax assets and liabilities, cash and borrowings.
The segment results for the period ended 31 May 2022 are as follows:
| 2022 - Unaudited | Aerospace & Industrial | Laboratory | Metal Melt Quality | Central | Group | ||||
| £'000 | £'000 | £'000 | £'000 | £'000 | |||||
| Total segment revenue | 30,769 | 31,797 | 20,820 | - | 83,386 | ||||
| Inter-segment revenue | (84) | (1,022) | - | - | (1,106) | ||||
| Revenue | 30,685 | 30,775 | 20,820 | - | 82,280 | ||||
| Adjusted operating profit/(loss) | 3,091 | 6,064 | 2,782 | (1,525) | 10,412 | ||||
| Amortisation of acquired intangible assets | (182) | (153) | - | - | (335) | ||||
| Operating profit/(loss) | 2,909 | 5,911 | 2,782 | (1,525) | 10,077 | ||||
| Finance costs | - | - | - | (566) | (566) | ||||
| Profit/(loss) before tax | 2,909 | 5,911 | 2,782 | (2,091) | 9,511 |
The segment results for the period ended 31 May 2021 are as follows:
| 2021 - Unaudited | Aerospace & Industrial | Laboratory | Metal Melt Quality | Central | Group | ||||
| £'000 | £'000 | £'000 | £'000 | £'000 | |||||
| Total segment revenue | 26,126 | 26,156 | 18,364 | - | 70,646 | ||||
| Inter-segment revenue | (81) | (911) | - | - | (992) | ||||
| Revenue | 26,045 | 25,245 | 18,364 | - | 69,654 | ||||
| Adjusted operating profit/(loss) | 2,455 | 4,753 | 2,994 | (1,136) | 9,066 | ||||
| Amortisation of acquired intangible assets | (211) | (191) | - | - | (402) | ||||
| Other acquisition-related adjustments | - | - | - | (80) | (80) | ||||
| Impairment of assets and restructuring | (592) | - | - | - | (592) | ||||
| Paycheck Protection Program | 407 | 295 | 635 | - | 1,337 | ||||
| Operating profit/(loss) | 2,059 | 4,857 | 3,629 | (1,216) | 9,329 | ||||
| Finance costs | - | - | - | (479) | (479) | ||||
| Profit/(loss) before tax | 2,059 | 4,857 | 3,629 | (1,695) | 8,850 |
The segment assets and liabilities at 31 May 2022 are as follows:
| At 31 May 2022 - Unaudited | Aerospace & Industrial | Laboratory | Metal Melt Quality | Central | Group | ||||
| £'000 | £'000 | £'000 | £'000 | £'000 | |||||
| Segmental assets | 77,124 | 57,114 | 30,777 | 244 | 165,259 | ||||
| Cash and cash equivalents | - | - | - | 15,988 | 15,988 | ||||
| Total assets | 77,124 | 57,114 | 30,777 | 16,232 | 181,247 | ||||
| Segmental liabilities | (20,481) | (15,358) | (7,015) | (6,492) | (49,346) | ||||
| Retirement benefit obligations | - | - | - | (7,102) | (7,102) | ||||
| Borrowings | - | - | - | (3,754) | (3,754) | ||||
| Total liabilities | (20,481) | (15,358) | (7,015) | (17,348) | (60,202) |
The segment assets and liabilities at 31 May 2021 are as follows:
| At 31 May 2021 - Unaudited | Aerospace & Industrial | Laboratory | Metal Melt Quality | Central | Group | ||||
| £'000 | £'000 | £'000 | £'000 | £'000 | |||||
| Segmental assets | 72,098 | 51,639 | 26,542 | 2,305 | 152,584 | ||||
| Cash and cash equivalents | - | - | - | 15,501 | 15,501 | ||||
| Total assets | 72,098 | 51,639 | 26,542 | 17,806 | 168,085 | ||||
| Segmental liabilities | (18,434) | (15,983) | (5,226) | (5,909) | (45,552) | ||||
| Retirement benefit obligations | - | - | - | (10,871) | (10,871) | ||||
| Borrowings | - | - | - | (9,349) | (9,349) | ||||
| Total liabilities | (18,434) | (15,983) | (5,226) | (26,129) | (65,772) |
The segment assets and liabilities at 30 November 2021 are as follows:
| At 30 November 2021 - Audited | Aerospace & Industrial | Laboratory | Metal Melt Quality | Central | Group | ||||
| £'000 | £'000 | £'000 | £'000 | £'000 | |||||
| Segmental assets | 70,038 | 51,720 | 30,087 | 2,322 | 154,167 | ||||
| Cash and cash equivalents | - | - | - | 15,442 | 15,442 | ||||
| Total assets | 70,038 | 51,720 | 30,087 | 17,764 | 169,609 | ||||
| Segmental liabilities | (19,242) | (12,675) | (5,747) | (5,180) | (42,844) | ||||
| Retirement benefit obligations | - | - | - | (12,602) | (12,602) | ||||
| Borrowings | - | - | - | (5,217) | (5,217) | ||||
| Total liabilities | (19,242) | (12,675) | (5,747) | (22,999) | (60,663) |
Geographical analysis
| Six months ended 31 May | |||||
| 2022 Unaudited |
2021 Unaudited |
||||
| Revenue | By destination £'000 |
By origin £'000 |
By destination £'000 |
By origin £'000 |
|
| United Kingdom | 8,735 | 25,794 | 6,717 | 19,840 | |
| Continental Europe | 18,961 | 10,146 | 15,693 | 12,447 | |
| United States of America | 37,171 | 43,961 | 29,949 | 34,550 | |
| Other NAFTA | 1,734 | - | 1,529 | - | |
| South America | 987 | - | 882 | - | |
| Asia | 13,558 | 2,379 | 14,312 | 2,817 | |
| Africa | 1,134 | - | 572 | - | |
| 82,280 | 82,280 | 69,654 | 69,654 |
3. Earnings per share (EPS)
| Six months ended 31 May | |||||||
| 2022 Unaudited |
2021 Unaudited |
||||||
| As reported | Earnings £'000 |
Weighted average number of shares | Per share amount Pence |
Earnings £'000 |
Weighted average number of shares | Per share amount Pence |
|
| Profit for the period - attributable to owners of the parent | 7,376 | 7,554 | |||||
| Shares in issue | 46,201,685 | 46,162,623 | |||||
| Shares owned by the Employee Benefit Trust | (289,162) | (167,788) | |||||
| Basic EPS | 7,376 | 45,912,523 | 16.1 | 7,554 | 45,994,835 | 16.4 | |
| Dilutive share options outstanding | - | 42,640 | - | - | 20,457 | - | |
| Diluted EPS | 7,376 | 45,955,163 | 16.1 | 7,554 | 46,015,292 | 16.4 |
In addition to the above, the Group also calculates an earnings per share based on adjusted profit as the Board believes this to be a better measure to judge the progress of the Group, as discussed in note 1.
| Six months ended 31 May | |||||||
| 2022 | 2021 | ||||||
| Adjusted | Earnings £'000 |
Unaudited Weighted average number of shares |
Per share amount Pence |
Earnings £'000 |
Unaudited Weighted average number of shares |
Per share amount Pence |
|
| Profit for the period - attributable to owners of the parent | 7,376 | 7,554 | |||||
| Adjusting items (note 1) | 268 | (735) | |||||
| Adjusted profit attributable to owners of the parent | 7,644 | 6,819 | |||||
| Adjusted basic EPS | 7,644 | 45,912,523 | 16.6 | 6,819 | 45,994,835 | 14.8 | |
| Adjusted diluted EPS | 7,644 | 45,955,163 | 16.6 | 6,819 | 46,015,292 | 14.8 |
4. Dividends per share
| Six months ended 31 May | |||||
| 2022 | 2021 | ||||
| Unaudited | Unaudited | ||||
| Per share | £'000 | Per share | £'000 | ||
| Final dividend approved | 3.5p | 1,606 | 3.3p | 1,517 |
The final dividend approved for the year ended 30 November 2021 was paid to shareholders on 1 June 2022.
The Directors have declared an interim dividend of 1.9 pence (2021: 1.8 pence) per share to be paid on 26 August 2022 to shareholders on the register at the close of business on 22 July 2022; the ex-dividend date is 21 July 2022.
5. Cash generated from operations
| Six months ended 31 May | ||||
| 2022 Unaudited £'000 |
2021 Unaudited £'000 |
|||
| Operating profit | 10,077 | 9,329 | ||
| Adjustments for: | ||||
| Post-employment benefits | (1,541) | (1,459) | ||
| Paycheck Protection Program loan waiver | - | (1,337) | ||
| Fair value movement of derivatives through profit and loss | 249 | (191) | ||
| Share-based payments | 387 | 306 | ||
| Depreciation of property, plant and equipment and amortisation of intangibles | 1,862 | 1,938 | ||
| Impairment of property plant and equipment | - | 270 | ||
| Depreciation of right-of-use assets | 1,098 | 979 | ||
| Loss on disposal of property, plant and equipment | 23 | - | ||
| Operating cash flows before movement in working capital | 12,155 | 9,835 | ||
| Increase in inventories | (3,044) | (1,019) | ||
| Increase in trade and other receivables | (6,162) | (1,400) | ||
| Increase/(decrease) in trade and other payables | 4,582 | (857) | ||
| Decrease in provisions | (292) | (481) | ||
| Increase in working capital | (4,916) | (3,757) | ||
| Cash generated from operations | 7,239 | 6,078 |
6. Reconciliation of net cash flow to movement in net debt
| Six months ended 31 May | |||
| 2022 Unaudited £'000 |
2021 Unaudited £'000 |
||
| Net debt at the beginning of the period | (2,006) | (8,735) | |
| Increase in cash and cash equivalents | 344 | 348 | |
| Decrease/(increase) in borrowings | 1,350 | (434) | |
| Decrease in lease liabilities | 878 | 416 | |
| Paycheck Protection Program loan waiver | - | 1,337 | |
| Effects of exchange rate changes | 176 | 467 | |
| Net cash/(debt) at the end of the period | 742 | (6,601) |
| Net cash and bank debt | 12,234 | 6,152 | |
| Lease liabilities | (11,492) | (12,753) | |
| Net cash/(debt) at the end of the period | 742 | (6,601) |
7. Contingent liabilities
At 31 May 2022, the Group has performance bonds totalling US$2.5 million and €0.4 million (30 November 2021: US$2.5 million and €0.8 million). The uncalled performance bonds are expected to be called or released no later than December 2024.
8. Provisions
| Dilapidations £'000 |
Warranty £'000 |
Total £'000 |
||||||
| At 1 December 2021 | 296 | 4,372 | 4,668 | |||||
| Utilisation of provision | - | (38) | (38) | |||||
| Release of provision | - | (164) | (164) | |||||
| Unwinding of discount | 16 | - | 16 | |||||
| Exchange difference | - | 7 | 7 | |||||
| At 31 May 2022 | 312 | 4,177 | 4,489 |
| Dilapidations £'000 |
Warranty £'000 |
Total £'000 |
||||||
| At 1 December 2020 | 268 | 4,365 | 4,633 | |||||
| Utilisation of provision | - | (399) | (399) | |||||
| Release of provision | - | (82) | (82) | |||||
| Unwinding of discount | 14 | - | 14 | |||||
| At 31 May 2021 | 282 | 3,884 | 4,166 |
Provisions arise from potential claims on major contracts, sale warranties, and discounted dilapidations for leased property. Matters that could affect the timing, quantum and extent to which provisions are utilised or released, include the impact of any remedial work, claims against outstanding performance bonds, and the demonstrated life of the filtration equipment installed.
9. Pension schemes
The Group supports its defined benefit pension scheme in the UK, which is closed to new members, and provides access to defined contribution schemes for its other employees. The Group's net retirement benefit obligation at 31 May 2022, measured in accordance with IAS 19 Employee Benefits, was £7.1 million (30 November 2021: £12.6 million). An actuarial gain in the period of £3.0 million, net of tax, was recognised in the condensed statement of comprehensive income, resulting primarily from an increase in the discount rate.
10. Exchange rates
Exchange rates for the US dollar and Euro during the period were:
| Average rate to 31 May 22 | Average rate to 31 May 21 | Closing rate at 31 May 22 | Closing rate at 30 Nov 21 | |
| Unaudited | Unaudited | Unaudited | Unaudited | |
| US dollar | 1.31 | 1.38 | 1.26 | 1.32 |
| Euro | 1.19 | 1.14 | 1.18 | 1.18 |
11. Seasonality
The results for the six months ended 31 May 2022 are impacted by a lower number of working days in the first six months of the year than in the second half of the year.
12. Basis of preparation
Porvair plc is a public limited company registered in the UK and listed on the London Stock Exchange.
This unaudited condensed interim consolidated financial information for the six months ended 31 May 2022 has been prepared in accordance with the Disclosure and Transparency Rules ('DTR') of the Financial Conduct Authority and with IAS 34 Interim Financial Reporting as contained in UK-adopted International Accounting Standards. The condensed interim consolidated financial information should be read in conjunction with the annual financial statements for the year ended 30 November 2021, which were prepared in accordance with applicable law and International Accounting Standards in conformity with the requirements of the Companies Act 2006 and International Financial Reporting Standards adopted pursuant to Regulation (EC) No 1606/2002 as it applies in the European Union.
The accounting policies applied in these interim financial statements are consistent with those applied in the Group's consolidated financial statements for the year ended 30 November 2021. A number of other new standards and amendments are effective from 1 December 2021 but they do not have a material effect on the Group's financial statements.
Taxes on income in the interim period are accrued using the tax rate that would be applicable to expected total annual earnings.
This condensed interim consolidated financial information has been prepared on a going concern basis under the historical cost convention, as modified by the recognition of certain financial assets and financial liabilities (including derivative financial instruments) at fair value through profit or loss.
The preparation of condensed interim consolidated financial information, in conformity with generally accepted accounting principles, requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the condensed interim consolidated financial information, and the reported amounts of revenues and expenses during the reporting period. Although these estimates are based on management's best knowledge of the amount, event or actions, actual results may ultimately differ from those estimates. In preparing the condensed interim financial statements, the significant judgements made by management in applying the Group's accounting policies and the key sources of estimation uncertainty were the same as those applied to the consolidated financial statements for the year ended 30 November 2021, with the exception of changes in estimates that are required in determining the provision for income taxes.
After having made appropriate enquiries, including a review of progress against the Group's budget for 2022, its current trading and medium-term plans; and taking into account the banking facilities available until May 2026, the Directors have a reasonable expectation that the Group has adequate resources to continue in operational existence for at least twelve months from the date of approval of the condensed interim consolidated financial information. Accordingly, they continue to adopt the going concern basis in preparing this condensed interim consolidated financial information.
This condensed interim consolidated financial information and the comparative figures do not constitute full accounts within the meaning of Section 434 of the Companies Act 2006. Statutory accounts for the year ended 30 November 2021, which were approved by the Board of Directors on 28 January 2022, and which include an unqualified audit report, no emphasis of matter paragraph and no statements under sections 498(2) or (3) of the Companies Act 2006, have been delivered to the Registrar of Companies. This condensed interim consolidated financial information has been reviewed, not audited.
The condensed interim consolidated financial information does not include all financial risk management information and disclosures required in the annual financial statements; it should be read in conjunction with the Group's annual financial statements for the year ended 30 November 2021. There have been no changes in any risk management policies since the year end.
This report will be available at Porvair plc's registered office at 7 Regis Place, Bergen Way, King's Lynn, PE30 2JN and on the Company's website, www.porvair.com.
Statement of directors' responsibilities
The Directors confirm that this condensed interim consolidated financial information has been prepared in accordance with IAS 34 Interim Financial Reporting as contained in UK-adopted International Accounting Standards, and that the interim management report herein includes a fair review of the information required by DTR 4.2.7 and DTR 4.2.8, namely:
· an indication of important events that have occurred during the first six months of the year, their impact on the condensed interim consolidated financial information and a description of the principal risks and uncertainties for the remaining six months of the financial year; and
· material related party transactions in the first six months of the year and any material changes in the related party transactions described in the last annual report.
The Directors of Porvair plc are listed in the Porvair plc Annual Report for the year ended 30 November 2021. A list of current Directors is maintained on the Porvair plc website, www.porvair.com.
By order of the board
| Ben Stocks | James Mills |
| Group Chief Executive 1 July 2022 |
Group Finance Director |
INDEPENDENT REVIEW REPORT TO PORVAIR PLC
Introduction
We have been engaged by the Company to review the condensed set of financial statements in the interim financial report for the six months ended 31 May 2022 which comprises the condensed consolidated income statement, the condensed consolidated statement of comprehensive income, the condensed consolidated balance sheet, the condensed consolidated cash flow statement, the condensed consolidated statement of changes in equity and related notes 1 to 12. We have read the other information contained in the interim financial report and considered whether it contains any apparent misstatements or material inconsistencies with the information in the condensed set of financial statements.
Directors' Responsibilities
The interim financial report, is the responsibility of, and has been approved by, the directors. The directors are responsible for preparing and presenting the interim financial report in accordance with the Disclosure Guidance and Transparency Rules of the United Kingdom's Financial Conduct Authority.
The annual financial statements of the Group will be prepared in accordance with UK-adopted International Accounting Standards. The condensed set of financial statements included in this interim financial report has been prepared in accordance with International Accounting Standard 34, "Interim Financial Reporting" as contained in UK-adopted International Accounting Standards.
Our Responsibility
Our responsibility is to express to the Company a conclusion on the condensed set of financial statements in the interim financial report based on our review.
Scope of Review
We conducted our review in accordance with International Standard on Review Engagements (UK and Ireland) 2410, "Review of Interim Financial Information Performed by the Independent Auditor of the Entity" issued by the Auditing Practices Board for use in the United Kingdom. A review of interim financial information consists of making enquiries, primarily of persons responsible for financial and accounting matters, and applying analytical and other review procedures. A review is substantially less in scope than an audit conducted in accordance with International Standards on Auditing (UK) and consequently does not enable us to obtain assurance that we would become aware of all significant matters that might be identified in an audit. Accordingly, we do not express an audit opinion.
Conclusion
Based on our review, nothing has come to our attention that causes us to believe that the condensed set of financial statements in the interim financial report for the six months ended 31 May 2022 is not prepared, in all material respects, in accordance with International Accounting Standard 34, "Interim Financial Reporting" as contained in UK-adopted International Accounting Standards, and the Disclosure Guidance and Transparency Rules of the United Kingdom's Financial Conduct Authority.
Use of our report
This report is made solely to the Company in accordance with International Standard on Review Engagements (UK and Ireland) 2410 "Review of Interim Financial Information performed by the Independent Auditor of the Entity" issued by the Auditing Practices Board and for the purpose of the Disclosure Guidance and Transparency Rules of the United Kingdom's Financial Conduct Authority. Our review work has been undertaken so that we might state to the Company those matters we are required to state to them in an independent review report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the Company, for our review work, for this report, or for the conclusions we have formed.
RSM UK Audit LLP
Chartered Accountants
25 Farringdon Street
London EC4A 4AB
1 July 2022
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
IR SSWFMFEESEFW